Results 291 to 300 of about 883,694 (328)
Some of the next articles are maybe not open access.

Cardiogenic shock

Critical Care Medicine, 2008
Cardiogenic shock is the most common cause of death in patients hospitalized with acute myocardial infarction and is associated with a poor prognosis. More than 75% of cases are due to extensive left ventricular infarction and ventricular failure. Other causes include right ventricular infarction and papillary muscle rupture with acute severe mitral ...
Simon, Topalian   +2 more
openaire   +4 more sources

Cardiogenic Shock

Cardiology Clinics, 1995
Despite advancements in the pharmacologic treatment of acute myocardial infarction and the introduction of mechanical hemodynamic support, in-hospital mortality rates for cardiogenic shock have remained between 70% and 80%. In addition, the proven beneficial effects of thrombolytic therapy in reducing mortality in acute myocardial infarction have not ...
M, Moscucci, E R, Bates
openaire   +2 more sources

Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population

Catheterization and cardiovascular interventions, 2022
Proposed phenotypes have recently been identified in cardiogenic shock (CS) populations using unsupervised machine learning clustering methods. We sought to validate these phenotypes in a mixed cardiac intensive care unit (CICU) population of patients ...
J. Jentzer   +4 more
semanticscholar   +1 more source

Cardiogenic Shock Cardiogenic Shock

, 2018
Cardiogenic shock (CS) is an end-organ hypoperfusion associated with heart failure. Any reason impairing acute left ventricular (LV) or right ventricular (RV) function may cause CS.
F. S. Türker
semanticscholar   +1 more source

The landscape of cardiogenic shock: epidemiology and current definitions

Current Opinion in Cardiology, 2022
Purpose of review Despite novel technologies for treating shock patients, cardiogenic shock mortality remains high. Trends of cardiogenic shock associated with acute myocardial infarction (AMI) have previously been described, though little is known about
Cesar Andrés Palacios Ordonez, A. Garan
semanticscholar   +1 more source

CARDIOGENIC SHOCK

Critical Care Clinics, 2001
Mortality rates in patients with cardiogenic shock remain frustratingly high. Its pathophysiology involves a downward spiral in which ischemia causes myocardial dysfunction, which in turn worsens ischemia. Areas of viable but nonfunctional myocardium can contribute to the development of cardiogenic shock.
openaire   +3 more sources

Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock.

New England Journal of Medicine
BACKGROUND The effects of temporary mechanical circulatory support with a microaxial flow pump on mortality among patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock remains unclear.
J. Møller   +35 more
semanticscholar   +1 more source

Cardiogenic Shock

Cardiology Clinics, 2013
Cardiogenic shock (CS) is a condition in which a marked reduction in cardiac output and inadequate end-organ perfusion results from an array of cardiac insults, the most common of which is acute myocardial infarction. CS is a systemic disease involving a vicious cycle of inflammation, ischemia, and progressive myocardial dysfunction, which often ...
Howard A, Cooper, Julio A, Panza
openaire   +2 more sources

Pathophysiology of cardiogenic shock

Current Opinion in Critical Care, 2021
Purpose of review We describe the pathophysiology of cardiogenic shock (CS), from the main pathways to the inflammatory mechanisms and the proteomic features. Recent findings Although the classical pathophysiological pathways underlying CS, namely reduced organ perfusion due to ...
Pietro Bertini, Fabio Guarracino
openaire   +3 more sources

Need for a Cardiogenic Shock Team Collaborative—Promoting a Team‐Based Model of Care to Improve Outcomes and Identify Best Practices

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease
Cardiogenic shock continues to carry a high mortality rate despite contemporary care, with no breakthrough therapies shown to improve survival over the past few decades.
Balimkiz C Senman   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy